Friday, Nov. 13, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $24.16 to $3,621,256.80.

Highlighted Stocks Traded by Insiders:

Monolithic Power Systems (MPWR) - FREE Research Report

Rao Meera, who is Cfo at Monolithic Power Systems, sold 4,139 shares at $64.16 on Nov. 13, 2015. Following this transaction, the Cfo owned 175,453 shares meaning that the stake was reduced by 2.3% with the 4,139-share transaction.

The shares most recently traded at $62.38, down $1.78, or 2.85% since the insider transaction. Historical insider transactions for Monolithic Power Systems go as follows:

  • 4-Week # shares sold: 59,265
  • 12-Week # shares sold: 84,275
  • 24-Week # shares sold: 123,748

The average volume for Monolithic Power Systems has been 304,600 shares per day over the past 30 days. Monolithic Power Systems has a market cap of $2.5 billion and is part of the technology sector and electronics industry. Shares are up 25.77% year-to-date as of the close of trading on Friday.

Monolithic Power Systems, Inc. designs, develops, and markets integrated power semiconductor solutions and power delivery architectures for communications, storage and computing, consumer electronics, and industrial/automotive markets. The stock currently has a dividend yield of 1.26%. The company has a P/E ratio of 75.4. Currently, there are 7 analysts who rate Monolithic Power Systems a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPWR - FREE

TheStreet Quant Ratings rates Monolithic Power Systems as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Monolithic Power Systems Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HealthEquity (HQY) - FREE Research Report

Sydney Matthew, who is Exec VP, Sales & Marketing at HealthEquity, sold 35,000 shares at $35.00 on Nov. 13, 2015. Following this transaction, the Exec VP, Sales & Marketing owned 100 shares meaning that the stake was reduced by 99.72% with the 35,000-share transaction.

The shares most recently traded at $32.68, down $2.32, or 7.1% since the insider transaction. Historical insider transactions for HealthEquity go as follows:

  • 4-Week # shares sold: 12,500
  • 12-Week # shares sold: 212,500
  • 24-Week # shares bought: 75,500
  • 24-Week # shares sold: 237,500

The average volume for HealthEquity has been 343,900 shares per day over the past 30 days. HealthEquity has a market cap of $1.9 billion and is part of the technology sector and computer software & services industry. Shares are up 27.98% year-to-date as of the close of trading on Friday.

HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company has a P/E ratio of 143.4. Currently, there are 7 analysts who rate HealthEquity a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HQY - FREE

TheStreet Quant Ratings rates HealthEquity as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the stock itself is trading at a premium valuation. Get the full HealthEquity Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Prospect Capital Corporation (PSEC) - FREE Research Report

Stark Eugene S, who is Director at Prospect Capital Corporation, bought 1,000 shares at $7.30 on Nov. 13, 2015. Following this transaction, the Director owned 30,000 shares meaning that the stake was boosted by 3.45% with the 1,000-share transaction.

The shares most recently traded at $7.43, up $0.13, or 1.75% since the insider transaction. Historical insider transactions for Prospect Capital Corporation go as follows:

  • 4-Week # shares bought: 1,000
  • 12-Week # shares bought: 1,000
  • 24-Week # shares bought: 497,060

The average volume for Prospect Capital Corporation has been 2.5 million shares per day over the past 30 days. Prospect Capital Corporation has a market cap of $2.6 billion and is part of the financial sector and financial services industry. Shares are down 11.26% year-to-date as of the close of trading on Friday.

Prospect Capital Corporation is a business development company. The stock currently has a dividend yield of 13.83%. The company has a P/E ratio of 7.3. Currently, there are 4 analysts who rate Prospect Capital Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PSEC - FREE

TheStreet Quant Ratings rates Prospect Capital Corporation as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full Prospect Capital Corporation Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.